Nalaganje...

Short-term clinical and serological follow-up with conventional and conformational anti-desmoglein antibodies in treatment-naïve and previously treated patients with pemphigus vulgaris after receiving rituximab

BACKGROUND: Pemphigus vulgaris (PV) is a blistering, life-threatening autoimmune disease. Ethylenediaminetetraacetic acid (EDTA)-treated desmoglein (Dsg) enzyme-linked immunosorbent assay (ELISA) has recently been suggested to detect nonpathogenic antibodies. Rituximab (RTX) is now considered a firs...

Popoln opis

Shranjeno v:

Bibliografske podrobnosti
izdano v:	Int J Womens Dermatol
Main Authors:	Alaeen, Hoorieh, Toosi, Roja, Mahmoudi, Hamidreza, Balighi, Kamran, Tavakolpour, Soheil, Teimoupour, Amir, Daneshpazhooh, Maryam
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2019
Teme:	Article
Online dostop:	https://ncbi.nlm.nih.gov/pmc/articles/PMC6938821/ https://ncbi.nlm.nih.gov/pubmed/31909160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijwd.2019.05.008
Oznake:	Označite Brez oznak, prvi označite!

Short-term clinical and serological follow-up with conventional and conformational anti-desmoglein antibodies in treatment-naïve and previously treated patients with pemphigus vulgaris after receiving rituximab

Podobne knjige/članki